Da Liu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Molecular Biology top 5%
- CRISPR and Genetic Engineering
- Extracellular vesicles in disease
- Advanced biosensing and bioanalysis techniques
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Advanced biosensing and bioanalysis techniques 10
- Epigenetics and DNA Methylation 8
- Ginseng Biological Effects and Applications 8
- Extracellular vesicles in disease 7
- RNA Interference and Gene Delivery 6
- Circular RNAs in diseases 6
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 7
- Co-authors
- Haoming Luo (8 shared papers)Donglu Wu (8 shared papers)Zhidong Qiu (7 shared papers)Zhidong Qiu (5 shared papers)Xue Meng (1 shared paper)Yao Zu (2 shared papers)Xiangjun Tong (3 shared papers)Zuoyan Zhu (2 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Frontiers in Pharmacology (5 papers)Sensors and Actuators B Chemical (5 papers)Pharmaceuticals (4 papers)Biomedicine & Pharmacotherapy (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Da Liu
127 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 160
- Cancer Research 287
- Molecular Biology 1.3k
- Sensory Systems 53
- Aging 18
- Pharmacology 77
Countries citing papers authored by Da Liu
This map shows the geographic impact of Da Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Liu more than expected).
Fields of papers citing papers by Da Liu
This network shows the impact of papers produced by Da Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Liu. The network helps show where Da Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 272 | |
| 2 | 2019 | 131 | |
| 3 | 2019 | 88 | |
| 4 | 2020 | 86 | |
| 5 | 2023 | 77 | |
| 6 | 2020 | 67 | |
| 7 | 2012 | 60 | |
| 8 | 2022 | 59 | |
| 9 | 2020 | 58 | |
| 10 | 2014 | 54 | |
| 11 | 2020 | 54 | |
| 12 | 2020 | 52 | |
| 13 | 2021 | 50 | |
| 14 | 2021 | 49 | |
| 15 | 2014 | 48 | |
| 16 | 2020 | 43 | |
| 17 | 2020 | 41 | |
| 18 | 2020 | 39 | |
| 19 | 2015 | 38 | |
| 20 | 2014 | 37 |
About Da Liu
Da Liu is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Immunology and Electrical and Electronic Engineering, having authored 137 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Advanced biosensing and bioanalysis techniques (10 papers), Epigenetics and DNA Methylation (8 papers), Ginseng Biological Effects and Applications (8 papers), Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (287 citations), Molecular Biology (1.3k citations), Sensory Systems (53 citations), Aging (18 citations) and Pharmacology (77 citations). Da Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Haoming Luo, Donglu Wu, Zhidong Qiu, Zhidong Qiu, Xue Meng, Yao Zu, Xiangjun Tong, Zuoyan Zhu, Shuo Lin and Bo Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Pharmacology, Sensors and Actuators B Chemical, Pharmaceuticals and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.